BPLBZ - O-4525, SULFANILAMIDE

  • MSDS: BPLBZ
  • Manufacturer: FISHER SCIENTIFIC
  • Product Name: O-4525, SULFANILAMIDE
  • National Stock Number: 6810-00N015831
Product Identification

Product ID:O-4525, SULFANILAMIDE
MSDS Date:05/18/1988
FSC:6810
NIIN:00N015831
MSDS Number: BPLBZ

Responsible Party
FISHER SCIENTIFIC
1 REAGENT LANE
FAIR LAWN, NJ 07410-2802
US

Emergency Phone: 201-796-7100

Info Phone: 201-796-7100

Cage: 1B464

Contractor
FISHER SCIENTIFIC CO. CHEMICAL MFG DIV
FAIRLAWN, NJ 07410-2802 US

Telephone: 201-796-7100

Cage: 1B464

Ingredients

PRESENCE OF SYMPS.) GIVE METHYLENE BLUE, 1% SOLN,

RTECS: 9999999ZZ


NOT AVAIL, GIVE ASCORBIC ACID, 1 GM SLOWLY IV.

RTECS: 9999999ZZ


ABOVE 40%. CONTINUE O*2 THERAPY FOR AT LEAST 2 HRS

RTECS: 9999999ZZ


BE GIVEN BY QUALIFIED MEDICAL PERSONNEL.

RTECS: 9999999ZZ


CYANOSIS. OTHER SYMPS MAY INCL CEREBRAL & GI EFTS

RTECS: 9999999ZZ


EVEN UNCON. TOX FEVER MAY DEVELOP ONE/MORE DAYS AFTER

RTECS: 9999999ZZ


OF MORE SERIOUS MANIFESTATIONS OF POISONING, NAMELY

RTECS: 9999999ZZ


AGRANULOCYTIC ANGINA, DERM OR TOX NEURITIS. JAUNDICE

RTECS: 9999999ZZ


SYMPS SIMILAR TO ACUTE

RTECS: 9999999ZZ


FROM ORAL ADMINISTRATION FOR 1-22 DAYS IN PREGNANT

RTECS: 9999999ZZ


HAZARD AREA & DENY ENTRY. VENTILATE CLOSED

RTECS: 9999999ZZ


TO MAX RESP PROT. CHEM CARTRIDGE RESP W/ORG VAP

RTECS: 9999999ZZ


FULL FACEPIECE. HIGH-EFFICIENCY PARTICULATE RESP

RTECS: 9999999ZZ


EFFICIENCY FILTER W/FULL FACEPIECE. TYPE "C"

RTECS: 9999999ZZ


OR OTHER POS PRESS MODE OR W/FULL FACEPIECE, HELMET

RTECS: 9999999ZZ


FULL FACEPIECE OPERATED IN PRESSURE-DEMAND OR OTHER

RTECS: 9999999ZZ


IF VICTIM IS CONSCIOUS, IMMED GIVE

RTECS: 9999999ZZ


TO BACK OF THROAT. GET MD IMMED.

RTECS: 9999999ZZ


SULFANILAMIDE

CAS: 63-74-1

RTECS: WO8400000

Fraction By Weight: 100%


MACULOPAPULAR ERYTHEMATOUS SKIN ERUPTIONS,

RTECS: 9999999ZZ


REPORTED. SYSTEMIC EFTS FROM ORAL ADMIN MAY INCL

RTECS: 9999999ZZ


ASTIGMATISM, CONJUNCT & TEMPORARY IMPAIRMENT OF DEPTH

RTECS: 9999999ZZ

Hazards

LD50 LC50 Mixture:LD50:(ORAL RAT) 10500 MG/KG
Routes of Entry: Inhalation:NO Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:SULFANILAMIDE IS A METHEMOGLOBIN
FORMER. POISONING MAY AFFECT LIVER/KIDNEYS. CONCURRENT ADMIN OF
VARIOUS DRUGS W/SULFANILAMIDE MAY CAUSE ADVERSE EFTS. TOPICAL OR
ORAL USE OF PARA-AMINOBENZOIC ACID ANT AGONIZED SULFONAMIDE EFT;
MARKEDLY INCRD ANTICOAGULANT EFTS W/ORAL ANTICOAGULANTS; POSS
ADDITIVE BONE (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ:MARROW DEPRESS W/CHLORAMPHENICOL; POSS
INCR HYPOGLYCEMA EFT W/ORAL HYPOGLYCEMIAS; POSS ADDITIVE
HEPATOTOXICITY W/HEPATOTOXINS; ACIDIFIES THE URINE, INCR POSS OF
SULFONAMIDE CRYSTALLURIA W/MET HENAMINE; INCR IN SERUM
METHOTREXATEE LEVELS, POSS LEADING TO TOX W/METHOTREXATE; MAY INCR
HEPATIC METABOLISM (SUP DAT)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.

First Aid

First Aid:INHAL:MOVE TO FRESH AIR IMMED. IF BRTHG HAS STOPPED, PERFORM
ARTF RESP. KEEP PERS WARM/AT REST. GET MD IMMED. SKIN:REMOVE
CONTAMD CLTHG/SHOES IMMED. WASH AFFECTED AREA W/SOAP/MILD DETERGENT
& LGE AMTS OF WATER FOR AT LEAST 15-20 MINS UNTILNO CHEM REMAINS.
GET MD IMMED. EYES:WASH IMMED W/LGE AMTS OF WATER, OCCASNLY LIFTING
UPPER/LOWER LIDS, UNTIL NO CHEM REMAINS (15-20 MINS). GET MD
IMMED.(ING 17)

Fire Fighting

Flash Point:NON-FLAMMABLE
Extinguishing Media:USE DRY CHEMICAL, CO*2, HALON, WATER SPRAY OR
STANDARD FOAM. LARGER FIRES USE WATER SPARY, FOG OR STANDARD FOAM
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT . NO ACUTE HAZARD. MOVE CONTR FROM FIRE AREA
IF POSS. AVOID BREATHING VAPORS/DUSTS. KEEP UPWIND.
Unusual Fire/Explosion Hazard:NEGLIGIBLE FIRE HAZARD WHEN EXPOSED TO
HEAT OR FLAME.

Accidental Release

Spill Release Procedures:OCCUP SPILL:DO NOT TOUCH SPILLED MATL. STOP
LEAK IF YOU CAN W/OUT RISK. SMALL SPILL:TAKE UP W/SAND OR OTHER
ABSORB MATL & PLACE INTO CONTRS FOR LATER DISP. LGE SPILL:DIKE FAR
AHEAD OF SPILL FOR LATER DISP. KEEP UNNEC PEOPLE AWAY. ISOLATE
(ING 11)
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling

Handling and Storage Precautions:NONE SPECIFIED BY MANUFACTURER.
Other Precautions:NONE SPECIFIED BY MANUFACTURER.

Exposure Controls

Respiratory Protection:SPECIFIC RESP SELECTED MUST BE BASED ON CONTAM
LEVELS FOUND IN WORK PLACE, MUST NOT EXCEED WORKING LIMITS OF RESP
& BE NIOSH/MSHA APPRVD. FOLLOWING RESPS ARE RECOM BASED ON DATA
FOUND IN MSDS. THEY AR E RANKED IN ORDER FROM MIN (ING 12)
Ventilation:PROVIDE LOCAL EXHAUST OR GENERAL DILUTION VENTILATION
SYSTEM.
Protective Gloves:IMPERVIOUS GLOVES .
Eye Protection:CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:WEAR APPROPRIATE PROTECTIVE (IMPERVIOUS)
CLTHG & EQUIP TO PREVENT RPTD/PRLNGD SKIN CONTACT W/THIS SUBSTANCE.
Work Hygienic Practices:CONTACT LENSES SHOULD NOT BE WORN.
Supplemental Safety and Health
PH:5.8-6.1 @ 0.5% SOLN. EFTS OF OVEREXP:OR DECR ABSORP OF ESTOGEN
W/ORAL CONTRACEPTIVES; INCR PHENYTOIN EFT, POSS LEADING TO TOX
W/PHENYOIN & OTHER HYDANTOINS; INCR THIOPENTAL LEVELS, POSS LEADING
TO TOX W/THIOPENTAL. ACUTE: INHAL:NO DATA AVAIL. SKIN:NO LOC EFTS
REPORTED. SYSTEMIC EFTS FROM ORAL ADMIN MAY INCL (ING 2)

Chemical Properties

HCC:N1
Melt/Freeze Pt:M.P/F.P Text:329F,165C
Spec Gravity:1.08
pH:SUPDAT
Solubility in Water:7.5%
Appearance and Odor:WHITE TO YELLOW POWDER.

Stability

Stability Indicator/Materials to Avoid:YES
NO DATA AVAILABLE.
Stability Condition to Avoid:NO DATA AVAILABLE.
Hazardous Decomposition Products:THERMAL DECOMPOSITION PRODUCTS INCLUDE
TOXIC OXIDES OF NITROGEN & SULFUR.

Disposal

Waste Disposal Methods:DISPOSAL MUST BE IN ACCORDANCE W/FEDERAL, STATE
& LOCAL REGULATIONS .

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.